Alfuzosine Sandoz 5 mg tabl. prol.-rel.

Nazione: Belgio

Lingua: inglese

Fonte: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Principio attivo:

Alfuzosin Hydrochloride 5 mg

Commercializzato da:

Sandoz SA-NV

Codice ATC:

G04CA01

INN (Nome Internazionale):

Alfuzosin Hydrochloride

Dosaggio:

5 mg

Forma farmaceutica:

Prolonged-release tablet

Composizione:

Alfuzosin Hydrochloride 5 mg

Via di somministrazione:

Oral use

Area terapeutica:

Alfuzosin

Dettagli prodotto:

CTI code: 294183-01 - Pack size: 20 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294183-09 - Pack size: 180 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294183-08 - Pack size: 100 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294183-07 - Pack size: 60 (60 x 1) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294183-06 - Pack size: 60 - Commercialisation status: NO - FMD code: 07613421000103 - CNK code: 2414936 - Delivery mode: Medical prescription; CTI code: 294183-05 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294183-04 - Pack size: 50 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294183-03 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 294183-02 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription

Stato dell'autorizzazione:

Commercialised: No

Data dell'autorizzazione:

2007-04-16